![]() |
|
|
Vol. 15, Issue 6, 2720-2728, June 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, California 93106
Submitted January 23, 2004;
Revised March 2, 2004;
Accepted March 3, 2004
Monitoring Editor: David Drubin
The neural microtubule-associated protein tau binds to and stabilizes microtubules. Because of alternative mRNA splicing, tau is expressed with either 3 or 4 C-terminal repeats. Two observations indicate that differences between these tau isoforms are functionally important. First, the pattern of tau isoform expression is tightly regulated during development. Second, mutation-induced changes in tau RNA splicing cause neuronal cell death and dementia simply by altering the isoform expression ratio. To investigate whether 3- and 4-repeat tau differentially regulate microtubule behavior in cells, we microinjected physiological levels of these two isoforms into EGFP-tubulinexpressing cultured MCF7 cells and measured the effects on the dynamic instability behavior of individual microtubules by time-lapse microscopy. Both isoforms suppressed microtubule dynamics, though to different extents. Specifically, 4-repeat tau reduced the rate and extent of both growing and shortening events. In contrast, 3-repeat tau stabilized most dynamic parameters about threefold less potently than 4-repeat tau and had only a minimal ability to suppress shortening events. These differences provide a mechanistic rationale for the developmental shift in tau isoform expression and are consistent with a loss-of-function model in which abnormal tau isoform expression results in the inability to properly regulate microtubule dynamics, leading to neuronal cell death and dementia.
Online version of this article contains supporting material. Online version is available at www.molbiolcell.org.
* Corresponding author. E-mail address: feinstei{at}lifesci.ucsb.edu.
This article has been cited by other articles:
![]() |
A. C. LeBoeuf, S. F. Levy, M. Gaylord, A. Bhattacharya, A. K. Singh, M. A. Jordan, L. Wilson, and S. C. Feinstein FTDP-17 Mutations in Tau Alter the Regulation of Microtubule Dynamics: AN "ALTERNATIVE CORE" MODEL FOR NORMAL AND PATHOLOGICAL TAU ACTION J. Biol. Chem., December 26, 2008; 283(52): 36406 - 36415. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Azarenko, T. Okouneva, K. W. Singletary, M. A. Jordan, and L. Wilson Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane Carcinogenesis, December 1, 2008; 29(12): 2360 - 2368. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Rosenberg, J. L. Ross, H. E. Feinstein, S. C. Feinstein, and J. Israelachvili Complementary dimerization of microtubule-associated tau protein: Implications for microtubule bundling and tau-mediated pathogenesis PNAS, May 27, 2008; 105(21): 7445 - 7450. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. McCaddon and P. R. Hudson Methylation and Phosphorylation: A Tangled Relationship? Clin. Chem., June 1, 2007; 53(6): 999 - 1000. [Full Text] [PDF] |
||||
![]() |
A. Kar, N. Havlioglu, W.-Y. Tarn, and J. Y. Wu RBM4 Interacts with an Intronic Element and Stimulates Tau Exon 10 Inclusion J. Biol. Chem., August 25, 2006; 281(34): 24479 - 24488. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Z. Yu and M. M. Rasenick Tau associates with actin in differentiating PC12 cells FASEB J, July 1, 2006; 20(9): 1452 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bunker, K. Kamath, L. Wilson, M. A. Jordan, and S. C. Feinstein FTDP-17 Mutations Compromise the Ability of Tau to Regulate Microtubule Dynamics in Cells J. Biol. Chem., April 28, 2006; 281(17): 11856 - 11863. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Khlistunova, J. Biernat, Y. Wang, M. Pickhardt, M. von Bergen, Z. Gazova, E. Mandelkow, and E.-M. Mandelkow Inducible Expression of Tau Repeat Domain in Cell Models of Tauopathy: AGGREGATION IS TOXIC TO CELLS BUT CAN BE REVERSED BY INHIBITOR DRUGS J. Biol. Chem., January 13, 2006; 281(2): 1205 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cunningham, L. J. Appleman, M. Kirvan-Visovatti, D. P. Ryan, E. Regan, S. Vukelja, P. L. Bonate, F. Ruvuna, R. J. Fram, A. Jekunen, et al. Phase I and Pharmacokinetic Study of the Dolastatin-15 Analogue Tasidotin (ILX651) Administered Intravenously on Days 1, 3, and 5 Every 3 Weeks in Patients with Advanced Solid Tumors Clin. Cancer Res., November 1, 2005; 11(21): 7825 - 7833. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Andorfer, C. M. Acker, Y. Kress, P. R. Hof, K. Duff, and P. Davies Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms J. Neurosci., June 1, 2005; 25(22): 5446 - 5454. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Levy, A. C. LeBoeuf, M. R. Massie, M. A. Jordan, L. Wilson, and S. C. Feinstein Three- and Four-repeat Tau Regulate the Dynamic Instability of Two Distinct Microtubule Subpopulations in Qualitatively Different Manners: IMPLICATIONS FOR NEURODEGENERATION J. Biol. Chem., April 8, 2005; 280(14): 13520 - 13528. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kamath, L. Wilson, F. Cabral, and M. A. Jordan {beta}III-Tubulin Induces Paclitaxel Resistance in Association with Reduced Effects on Microtubule Dynamic Instability J. Biol. Chem., April 1, 2005; 280(13): 12902 - 12907. [Abstract] [Full Text] [PDF] |
||||